Company Filing History:
Years Active: 2013
Title: Mirela Andrei: Innovator in Integrin Imaging and Therapy
Introduction
Mirela Andrei is a distinguished inventor based in Ploiesti, Romania. She has made significant contributions to the field of biomedical research, particularly in the development of ligands for integrin imaging and therapy. Her innovative work aims to improve treatment options for various diseases, including cancer and autoimmune disorders.
Latest Patents
Mirela Andrei holds a patent for "Heterocyclic ligands for integrin imaging and therapy." This invention provides αβ integrin ligands that exhibit high binding affinity, specificity, and stability. The ligands consist of a peptide with n independently selected amino acids, where at least one amino acid is either an unnatural amino acid or a D-amino acid, and n ranges from 3 to 20. The patent outlines methods for administering these ligands to treat cancer, inflammatory diseases, and autoimmune diseases. Additionally, it includes methods for using the ligands in imaging tumors, organs, or tissues in a subject.
Career Highlights
Mirela Andrei is affiliated with the University of California, where she continues her research and development efforts. Her work has garnered attention for its potential impact on medical therapies and diagnostics.
Collaborations
Mirela has collaborated with notable colleagues, including Richard D Carpenter and Ruiwu Liu, enhancing the scope and depth of her research initiatives.
Conclusion
Mirela Andrei's innovative contributions to integrin imaging and therapy exemplify her commitment to advancing medical science. Her patent and ongoing research hold promise for improving treatment strategies for serious health conditions.